Table 1 Baseline characteristics of participants (N = 1230), n (%), unless otherwise specified

From: Task-sharing and telemedicine delivery of psychotherapy to treat perinatal depression: a pragmatic, noninferiority randomized trial

Variable (total respondents)

Overall (N = 1,230)

Provider conditions

Modality conditions

Nonspecialist provider (n = 617)

Specialist provider (n = 613)

Telemedicine (n = 941)

In-person (n = 289)

Age in years (1,226)a, mean (95% CI)

33.27 (33.00–33.55)

33.26 (32.86–33.66)

33.29 (32.91–33.68)

33.06 (32.74–33.38)

33.97 (33.40–34.53)

Perinatal period at enrollment (1,230)a

 Pregnant

618 (50.24)

305 (49.43)

313 (51.06)

477 (50.69)

141 (48.79)

 Postpartum

612 (49.76)

312 (50.57)

300 (48.94)

464 (49.31)

148 (51.21)

Gestational age (1,230)

 Weeks pregnant

23.72 (23.17–24.27)

23.79 (23.01–24.57)

23.65 (22.88–24.43)

23.95 (23.33–24.57)

22.94 (21.74–24.15)

 Weeks postpartum

12.77 (12.20–13.34)

12.81 (12.01–13.61)

12.73 (11.91–13.55)

13.12 (12.46–13.78)

11.68 (10.54–12.82)

Race/ethnicity (1,226)a

 American Indian/Alaska Native

5 (0.41)

1 (0.16)

4 (0.66)

4 (0.43)

1 (0.35)

 Asian

209 (17.05)

114 (18.51)

95 (15.57)

160 (17.08)

49 (16.95)

 Black/African American

124 (10.11)

59 (9.58)

65 (10.66)

86 (9.18)

38 (13.15)

 Hawaiian/Pacific Islander

4 (0.33)

2 (0.33)

2 (0.33)

2 (0.21)

2 (0.69)

 White

614 (50.08)

311 (50.49)

303 (49.67)

473 (50.48)

141 (48.79)

 Multi-race

100 (8.16)

44 (7.14)

56 (9.18)

79 (8.43)

21 (7.27)

 Hispanic (Latino/Latina)

101 (8.24)

48 (7.79)

53 (8.69)

77 (8.22)

24 (8.30)

 Other

35 (2.85)

19 (3.08)

16 (2.62)

29 (3.09)

6 (2.08)

 Prefer not to answer

34 (2.77)

18 (2.92)

16 (2.62)

27 (2.88)

7 (2.42)

Born in country of current residence (1,226)a

860 (70.15)

433 (70.29)

427 (70.00)

653 (69.69)

207 (71.63)

Private health benefits (948)b ∆

654 (68.99)

327 (69.13)

327 (68.84)

466 (69.45)

188 (67.87)

Marital status (1,226)a

 Married or stable relationship

1052 (85.81)

528 (85.71)

524 (85.90)

806 (86.02)

246 (85.12)

 Single

94 (7.67)

47 (7.63)

47 (7.70)

71 (7.58)

23 (7.96)

 Dating

41 (3.34)

19 (3.08)

22 (3.61)

31 (3.31)

10 (3.46)

 Other

21 (1.71)

11 (1.79)

10 (1.64)

14 (1.49)

7 (2.42)

 Prefer not to answer

18 (1.47)

11 (1.79)

7 (1.15)

15 (1.60)

3 (1.04)

Gender identity (1,173)b

 Cis-woman

1,168 (99.57)

585 (99.32)

583 (99.83)

881 (99.44)

287 (100)

Sexual orientation (1,173)b

 Straight/heterosexual

1,073 (91.47)

531 (90.15)

542 (92.81)

810 (91.42)

263 (91.64)

 Bisexual

71 (6.05)

42 (7.13)

29 (4.97)

52 (5.87)

19 (6.62)

 Other

7 (0.60)

3 (0.51)

4 (0.68)

6 (0.68)

1 (0.35)

 Prefer not to answer

22 (1.88)

13 (2.21)

9 (1.54)

18 (2.03)

4 (1.39)

Highest level of education completed (1,226)a

 University degree

859 (70.07)

432 (70.13)

427 (70.00)

655 (69.90)

204 (70.59)

 College/trade school

216 (17.62)

104 (16.88)

112 (18.36)

161 (17.18)

55 (19.03)

 High school or less

141 (11.50)

76 (12.34)

65 (10.66)

112 (11.95)

29 (10.03)

 Prefer not to answer

10 (0.81)

4 (0.65)

6 (0.98)

9 (0.96)

1 (0.35)

Employment (1,226)a

 Full time

484 (39.48)

238 (38.64)

246 (40.33)

366 (39.06)

118 (40.83)

 Maternity leave

353 (28.79)

182 (29.55)

171 (28.03)

268 (28.60)

85 (29.41)

 Part time

111 (9.05)

53 (8.60)

58 (9.51)

83 (8.86)

28 (9.69)

 Not employed

260 (21.21)

133 (21.59)

127 (20.82)

207 (22.09)

53 (18.34)

 Other

18 (1.47)

10 (1.62)

8 (1.31)

13 (1.39)

5 (1.73)

Annual income (US$) based on zip code (1,138), mean (95% CI)

43,165.59 (42,236.47–44,094.70)

43,318.76 (41,946.93– 44,690.58)

43,016.14 (41,756.00– 44,276.28)

43,493.40 (42,390.31–44,596.48)

42,141.77 (40,460.83– 43,822.72)

Nulliparous (1,226)a

668 (54.49)

333 (54.06)

335 (54.92)

524 (55.92)

144 (49.83)

COVID-19 exposure (1,064)b

31 (2.91)

16 (2.98)

15 (2.85)

22 (2.80)

9 (3.25)

Self-reported history of depression/anxiety (1,226)a

1,051 (85.73)

528 (85.71)

523 (85.74)

805 (85.91)

246 (85.12)

Psychotropic medication use at baseline (1,226)c

288 (23.49)

138 (22.40)

150 (24.59)

227 (24.12)

61 (21.40)

Pregnancy conditions during current pregnancy (≥1) (1,075)b

265 (24.65)

125 (23.06)

140 (26.27)

192 (24.06)

73 (26.35)

 Preeclampsia

52 (4.84)

27 (4.98)

25 (4.69)

36 (4.51)

16 (5.78)

 Gestational hypertension

127 (11.81)

66 (12.18)

61 (11.44)

82 (10.28)

45 (16.25)

 Gestational diabetes

121 (11.26)

56 (10.33)

65 (12.20)

85 (10.65)

36 (13.00)

 Preterm labor

69 (6.42)

30 (5.54)

39 (7.32)

51 (6.39)

18 (6.50)

Symptom scores at baseline

 Depressive symptoms (EPDS)

 Total (0–30), mean (95% CI)

15.77 (15.56–15.99)

15.64 (15.34–15.94)

15.91 (15.60–16.22)

15.80 (15.55–16.04)

15.70 (15.25–16.15)

 Anxiety symptoms (GAD-7)

 Total (0–21) mean (95% CI)

11.85 (11.58–12.12)

11.94 (11.57–12.31)

11.75 (11.35–12.16)

11.82 (11.51–12.14)

11.93 (11.38–12.49)

Modality preference at baseline (1,203)b

 Telemedicine

747 (62.09)

 In-person

190 (15.79)

 No preference

266 (22.11)

Provider preference at baseline (1,203)b

 Specialist provider

730 (60.68)

 Nonspecialist provider

22 (1.83)

 No preference

451 (37.49)

  1. aFour participants did not complete the baseline assessment.
  2. bThis question was added after the trial commencement (in Spring 2020).
  3. cThis question is a subquestion of another question.
  4. All Canadian participants have government insurance and some also have supplemental private insurance.
  5. See Supplementary Tables 3 and 4 for baseline characteristics of participants by hub and arm, respectively, and Supplementary Table 5 (refs. 44,45,46,47,48,49,50,51,52,53,54,55,56) for the representativeness of trial participants.